REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 72 filers reported holding REPARE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,995,290 | +14.2% | 165,173 | 0.0% | 0.92% | +15.5% |
| Q2 2023 | $1,747,530 | +7.7% | 165,173 | +0.2% | 0.80% | -39.5% |
| Q1 2023 | $1,622,518 | -33.1% | 164,890 | 0.0% | 1.32% | -8.2% |
| Q4 2022 | $2,425,532 | -34.3% | 164,890 | -45.8% | 1.44% | -31.7% |
| Q3 2022 | $3,690,000 | +72.8% | 304,181 | +99.3% | 2.11% | +63.5% |
| Q2 2022 | $2,135,000 | +4.6% | 152,600 | +6.4% | 1.29% | -0.7% |
| Q1 2022 | $2,042,000 | +122.7% | 143,375 | +229.6% | 1.30% | +77.8% |
| Q4 2021 | $917,000 | -3.2% | 43,497 | +20.5% | 0.73% | +16.4% |
| Q3 2021 | $947,000 | – | 36,104 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,532,150 | $86,853,000 | 24.47% |
| MPM ASSET MANAGEMENT LLC | 3,003,772 | $103,029,000 | 14.58% |
| MPM BioImpact LLC | 4,776,674 | $163,840,000 | 14.15% |
| BVF INC/IL | 2,972,191 | $101,946,000 | 4.01% |
| Logos Global Management LP | 676,894 | $23,217,000 | 1.99% |
| Redmile Group, LLC | 2,647,696 | $90,816,000 | 1.10% |
| Orbimed Advisors | 3,426,325 | $117,523,000 | 1.03% |
| CLOUGH CAPITAL PARTNERS L P | 280,979 | $9,638,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,300 | $7,693,000 | 0.68% |
| Artal Group S.A. | 570,000 | $19,551,000 | 0.42% |